EMA Recommends Suspending Protelos (Strontium) for Osteoporosis

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended that Protelos/Protos/Osseor should no longer be used to treat osteoporosis.

Following an in-depth review taking into account available data on the benefits and risks of the medicine, the agency finds that the drug may pose serious heart problems (including heart attacks), blood clots, and a number of other risks, such as serious skin reactions, disturbances in consciousness, seizures, liver inflammation and reduced number of blood cells.

Protelos/Osseor (strontium ranelate) is authorized in the EU to treat severe osteoporosis (a disease that makes bones fragile) in women who have been through menopause and who are at high risk of fracture (broken bones) in the spine and the hip. It is also used to treat severe osteoporosis in men who are at increased risk of fracture.

Institute for Better Bone Health strongly agrees with the EMA’s recommendation and has been educating American consumers about the risks of strontium for osteoporosis for years.

Strontium ranelate is not approved by the FDA for use in the United States. Several supplement makers continue to use strontium in bone health supplements, against the FDA and now the EMA’s recommendations, posing a great danger to US consumers.

These supplements claim they are safe because they use a patented form of strontium (called strontium citrate), not strontium renelate. It is not the form of strontium that is dangerous – it is the strontium ions themselves. Strontium in any form is not essential to maintaining bone health and the current trend of supplementing with excessive minerals and questionable nutrients for bone health is very concerning.

Until strontium supplements have been rigorously tested in large scientific studies they should not available to the public and marketed as a “treatment” for osteoporosis.

Today’s announcement validates our efforts to protect consumers and we are one step closer to having strontium supplements removed from shelves completely.

Osteoporosis runs deep in our families. Our wives and mothers suffer with osteoporosis and we have been treating our family of patients with care and respect for decades. We would never recommend strontium to our patients, and owe that same level of personalized care to our valued customers.

Our Silical supplements* do not contain strontium in any form. Silical contains 100% food-based vitamins and minerals that may reduce the risk of osteoporosis, as part of a natural bone health program.

*Adequate calcium and vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.

2 thoughts on “EMA Recommends Suspending Protelos (Strontium) for Osteoporosis”

  • Patricia Mattiuz
    Patricia Mattiuz February 18, 2015 at 4:03 pm

    I am 70 years old and have osteopenia and had a humerus fracture at age 55 My Dr. Wants me to have the Prolia injection. I have read up on it and do not like all the side effects that may result. I do have stomach irritation with some drugs ie. Ibeprofins but can tolerate tylenol ok . My sister has been using your products for about a year now and feels that her levels have changed as of her last bone density. I would like to give this supplement a try and would like to know if I could receive it in Canada. Would appreciate your comments. Thank you PM

    Reply
    • Liqui-Site

      We are happy to hear about your sister's experience with our products. As you know the Silical System is designed to support bone health. At the current time, we do not have a distributor in Canada. Please call our customer service number 1-800-242-6149 so we can discuss further. Thank you.

      Reply
Leave a Reply